![Logo der Firma Evotec AG](http://cdn.pressebox.de/f/1d5bfabd8ed27cbc/logos/87775/500_500.gif)
DeveloGen and Teva Enter into Exclusive License Agreement for DeveloGen's Protein Kinase B Technology for the Treatment of Cancer
DeveloGen Israel Limited ("DeveloGen"), a wholly owned subsidiary of DeveloGen AG, today announced that DeveloGen, throu…